Advertisement
News
Subscribe to MDT Magazine News

Perrigo Announces Conclusion of the FDA Re-Inspection

April 12, 2011 9:35 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., April 12, 2011 /- Perrigo (Nasdaq: PRGO ; TASE) today announced that the Detroit Office of the Food and Drug Administration (FDA) has concluded its re-inspection of Perrigo's Allegan facility. The FDA has informed Perrigo that, effective immediately, the Company has an...

TOPICS:

Sanofi-aventis CEO Viebacher details strategy post-Genzyme buyout

April 12, 2011 8:40 am | by Mass High Tech: The Journal of New England Technology | Comments

Sanofi-aventis CEO Chris Viebacher outlined the research and development strategy that led to the purchase of Cambridge-based Genzyme Corp. for $20.1 billion and will lead the company to further expand its partnerships and acquisitions.

Top 30 MEMS Companies 2010: Big four capture a third of the total MEMS market

April 12, 2011 8:40 am | by I-Micronews | Comments

The MEMS industry had a great 25% growth year in 2010--but the four largest companies grew even faster, to increase their domination of Yole Développement's annual Top30 MEMS company ranking, and of the sector as a whole. These giants now account for some $2.9 billion of the sector's $8.6...

Advertisement

Allen Institute for Brain Science Announces First Comprehensive Gene Map of the Human Brain

April 12, 2011 8:37 am | by Bio-Medicine.Org | Comments

SEATTLE, April 12, 2011 /- The Allen Institute for Brain Science has released the world's first anatomically and genomically comprehensive human brain map, a previously unthinkable feat made possible through leading-edge technology and more than four years of rigorous studies and...

TOPICS:

Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study

April 12, 2011 8:37 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., April 12, 2011 /- Max Neeman meets enrollment and timeline of 15,000 for a large, Phase IV metabolic disorder trial across 1200 sites throughout India. As a leading Indian CRO, the company has completed multiple Phase IV studies for global sponsors with...

TOPICS:

NOMAD by Aribex Receives Edison Best New Product Award

April 12, 2011 8:36 am | by Bio-Medicine.Org | Comments

OREM, Utah, April 12, 2011 /- Aribex, Inc., the worldwide leader in handheld x-ray technologies, has been honored with a Silver Award from the internationally-known 2011 Edison Best New Product Awards™. The winners were announced April 5 during a ceremony at the historic Capitale...

TOPICS:

Pediatric-specific research needed to reduce health care-associated infections among children

April 12, 2011 8:35 am | by EurekAlert | Comments

(JAMA and Archives Journals) There are differences between adult and pediatric patients regarding the appropriate treatment and prevention efforts for health-care associated infections, highlighting a need for pediatric-specific quality measures to guide infection prevention and treatment...

TOPICS:

Sanofi-aventis CEO Viebacher detaiils strategy post-Genzyme buyout

April 12, 2011 7:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Sanofi-aventis CEO Chris Viebacher outlined the research and development strategy that led to the purchase of Cambridge-based Genzyme Corp. for $20.1 billion and will lead the company to further expand its partnerships and acquisitions.

Advertisement

Alliance HealthCare acquires US Radiosurgery

April 12, 2011 6:45 am | by The Associated Press | Comments

Alliance HealthCare Services has acquired US Radiosurgery LLC for about $43 million in cash, the company said Tuesday.Alliance provides diagnostic imaging and radiation for cancer treatment. US Radiosurgery is based in Nashville, Tenn., and it runs eight radiosurgery centers in eight different...

Use of combination drug regimen for treating TB may represent an effective treatment option

April 12, 2011 6:41 am | by EurekAlert | Comments

(JAMA and Archives Journals) In patients with newly diagnosed tuberculosis, use of a combined 4-drug fixed-dose regimen was found to have comparable outcomes to drugs administered separately, according to a study in the April 13 issue of JAMA, a theme issue on infectious disease...

TOPICS:

Genzyme CEO Termeer joins Aveo board

April 12, 2011 6:40 am | by Mass High Tech: The Journal of New England Technology | Comments

Outgoing Genzyme Corp. chairman, CEO and president Henri A. Termeer has been appointed to the board of directors for Aveo Pharmaceuticals Inc., a Cambridge company focused on cancer therapeutics.

Asante Solutions, Inc. Receives CE Mark for Pearlâ„¢ Insulin Pump

April 12, 2011 6:38 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., April 12, 2011 /- Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, today announced it received the CE mark for its Pearl Insulin Pump, the only insulin pump that uses a pre-filled insulin cartridge. The CE mark is a European proof of...

TOPICS:

Visual Healthcare to Support Chinese Clinical Trials

April 12, 2011 6:38 am | by Bio-Medicine.Org | Comments

RENO, Nev., April 12, 2011 /- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) announces today that work has begun on a Chinese based adaptation of the information technology grid that its clients use in their clinical trial applications. This project has been launched in...

TOPICS:

Study Provides New Means for Classifying E. Coli Bacteria & Testing for Fecal Contamination

April 12, 2011 5:38 am | by Georgia Tech Institute of Technology | Comments

The meaning of the standard fecal coliform test used to monitor water quality has been called into question by a new study that identified sources of Escherichia coli bacteria that might not indicate an environmental hazard.

Lanx®, Inc. Launches Durango™ Stand-Alone ALIF System

April 12, 2011 5:35 am | by Bio-Medicine.Org | Comments

BROOMFIELD, Colo., April 12, 2011 /- Lanx®, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the initial launch of its Durango™ Stand-Alone ALIF System (Durango), following 510(k)...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading